Organigram Announces Stock Option Grant

About this update from Organigram Global Inc.

[{"type":"text","content":"\n\n\n\nOrganigram Announces Stock Option Grant\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nMONCTON, NB, Feb. 2, 2018\n\n\n\nMONCTON, NB, Feb. 2, 2018 /CNW/ - Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the \"Company\" or \"Organigram\"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, announces that it has granted stock options for a total of 360,000 common shares of Organigram to employees and a director of the Company. In accordance with prior commitments, 25,000 of these stock options are exercisable at $5.50 per stock option; 280,000 of these stock options are exercisable at $4.83 per stock option; and, 55,000 of these stock options are exercisable at $4.30 per stock option.  All options will expire on February 1, 2028.  \n\nThis stock option grant is subject to TSX Venture Exchange approval.\n\nFor more information, visit www.Organigram.ca.\n\nAbout Organigram Holdings Inc.\n\nOrganigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (\"ACMPR\"). \n\nOrganigram has been ranked in the top ten Clean Technology & Life Sciences Sector on the TSX Venture Exchange 50. \n\nNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.\n\nThis news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectations. Important factors - including the availability of funds, consummation of definitive documentation, the results of financing efforts, crop yields - tha...

More updates from Organigram Global Inc.